Novartis to drop legal case against NHS body
Novartis will drop its legal case against an NHS body that was refusing to fund its eye drug Lucentis.
Read MoreAuthor: Ben Adams
NHS finances given clean bill of health – for now
NHS performance is continuing to hold up well, but concerns abound that quality of care may suffer from financial pressures.
Read MoreUK public oppose Cancer Drugs Fund – but in favour of VBP
The public oppose England’s Cancer Drugs Fund but support the new pricing system for branded medicines.
Read MoreGSK’s Peter Harding becomes new PAGB president
Peter Harding, currently general manager of GlaxoSmithKline Consumer Healthcare, has taken over as the new president of PAGB, the UK trade association for manufacturers of over-the-counter medicines and food supplements.
Read MoreBoehringer launches Syrum to the public
Under the auspices of London’s Science Museum John Pugh, director of digital at Boehringer Ingelheim and brainchild of the Syrum game, launched his company’s newest offering to the world.
Read More- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
